Melanoma is a highly aggressive cancer with an alarmingly increasing incidence. A major question in melanoma biology is why are red-haired individuals at a high risk of developing melanoma. Variants in the melanocortin-1-receptor (MC1R) gene, encoding a trimeric G protein- coupled receptor activated by a-melanocyte-stimulating hormone (a-MSH), are frequently associated with red or blonde hair, fair skin, freckling and skin sensitivity to ultraviolet (UV) light, and several (RHC-variants) also associate with increased melanoma risk. Several of these variants are associated with increased melanoma risk. However, not all of these associations have been attributed to phenotype, suggesting that some variants affect melanoma risk independent of phenotype. Using an in vivo model system, we recently reported that some MC1R mutations synergize with UV to induce melanoma independently of their effects on pigmentation. Understanding precisely how MC1R RHC-variants differentially affect melanoma biology is therefore a key issue. Importantly, we also reported recently that UV irradiation triggered MC1R-interaction with and degradation of PTEN, leading to increased PI3K- signalling-driven senescence in melanocytes, but senescence bypass in BRaf mutant melanoma. Importantly, WT MC1R but not red-hair associated MC1R RHC-variants could interact with PTEN. Here, we will use newly generated MC1R conditional RHC-variant mouse models to dissect the tumor suppressive functions of MC1R in melanoma initiation in vivo and specifically its role in controlling PI3K signaling via PTEN degradation. We will also undertake the in-depth mechanistic studies required to identify potential targets for therapeutic intervention. Finally, we will develop novel preventive and therapeutic strategies in melanoma guided by the in-depth molecular mechanism(s) in the MC1R/PTEN interaction. Our proposed studies will identify intracellular molecular targets of MC1R in suppressing melanoma initiation that are directed towards identifying novel strategies for melanoma prevention and therapeutic intervention.

Public Health Relevance

Recently we provided a key insight into why red-haired individuals are at a high risk of developing melanoma. Therefore, we aim to build on the insights obtained from our previous work to use physiologically relevant animal models and undertake the in-depth mechanistic studies required to identify potential targets for therapeutic intervention. Finally we will develop novel preventive and therapeutic strategies in melanoma guided by the in-depth molecular mechanisms in the MC1R/PTEN interaction.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA196896-01
Application #
8942627
Study Section
Cancer Etiology Study Section (CE)
Program Officer
Okano, Paul
Project Start
2015-07-15
Project End
2020-06-30
Budget Start
2015-07-15
Budget End
2016-06-30
Support Year
1
Fiscal Year
2015
Total Cost
$374,464
Indirect Cost
$145,714
Name
Boston University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Chen, Shuyang; Zhu, Bo; Yin, Chengqian et al. (2017) Palmitoylation-dependent activation of MC1R prevents melanomagenesis. Nature 549:399-403